Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "company"

5399 News Found

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth
News | April 30, 2026

RPG Life Sciences reports Rs 707.5 crore revenue in FY26, 8% annual growth

In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action
Supply Chain | April 30, 2026

Eli Lilly flags counterfeit Mounjaro products in Gurugram, backs regulatory action

Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies


Barentz to showcase clinically proven nutraceutical solutions at Vitafoods Europe 2026
Healthcare | April 30, 2026

Barentz to showcase clinically proven nutraceutical solutions at Vitafoods Europe 2026

Company to highlight science-backed actives, nature-powered ingredients, and its new “Natural by Barentz” private label platform in Barcelona


BD, Suttons Creek partner to streamline combination product development
R&D | April 30, 2026

BD, Suttons Creek partner to streamline combination product development

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration